Role of Homoeopathic medicines in treatment of Cervical Cancer
Not Applicable
- Conditions
- Health Condition 1: C53- Malignant neoplasm of cervix uteri
- Registration Number
- CTRI/2024/04/065500
- Lead Sponsor
- Bakson Homoeopathic Medical College and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Females with confirmed diagnosis of cervical cancer undergoing standard chemo and or radiotherapy
2.Participants with a score of 0-2 on Eastern Cooperative Oncology Group ECOG performance scale
Exclusion Criteria
1.Participants with uncontrolled systemic or psychiatric illnesses leading to cognitive impairment.
2.Participants diagnosed with metastatic cancer.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expected positive changes in scoring of scales EORTC QLQ-C30 and QLQ-CX24Timepoint: 15 months study <br/ ><br>11 months enrolment <br/ ><br>Follow ups-for participants enrolled in first 7 months will be followed up monthly for 6 months <br/ ><br>For participants enrolled in last 3 months will be followed up monthly for 4 months <br/ ><br>Scales assessed every 2 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method ILTimepoint: N/A